These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 121849)
61. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy. Languillon J; Yawalkar SJ; McDougall AC Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454 [No Abstract] [Full Text] [Related]
62. 4:4 diacetyl-diamino-diphenyl sulphone in the treatment of leprosy. Kundu S; Ghosh S Bull Calcutta Sch Trop Med; 1972 Apr; 20(2):30-1. PubMed ID: 4666676 [No Abstract] [Full Text] [Related]
63. Ecological considerations on treatment of leprosy. Bergel M Nihon Rai Gakkai Zasshi; 1983; 52(1):58-61. PubMed ID: 6381451 [No Abstract] [Full Text] [Related]
65. [Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy]. Pattyn SR; Husser JA; Saint-André P Acta Leprol; 1986; 4(4):445-6. PubMed ID: 3296614 [TBL] [Abstract][Full Text] [Related]
66. [Combined treatments consisting of rifampicin in periodic doses: the experience in Niger]. Soga G; Blanc L; Alfa C; Grosset J; Xavier S Acta Leprol; 1986; 4(4):397-407. PubMed ID: 3296609 [No Abstract] [Full Text] [Related]
67. Clinical trial of DADDS in lepromatous leprosy. Ganapati R; Naik SS; Shah MH; Shirsat LS; Gaitonde BB Lepr India; 1976 Jul; 48(3):238-43. PubMed ID: 799207 [TBL] [Abstract][Full Text] [Related]
68. Follow up study of thirty-six borderline cases of leprosy. Kundu S; Ghosh S Bull Calcutta Sch Trop Med; 1967 Jul; 15(3):103-4. PubMed ID: 5616299 [No Abstract] [Full Text] [Related]
69. Ocular leprosy in West Malaysia. Search for a posterior segment lesion. Weerekoon L Br J Ophthalmol; 1972 Feb; 56(2):106-13. PubMed ID: 5010311 [No Abstract] [Full Text] [Related]
70. DNA damage studies in untreated and treated leprosy patients. Gandhi G; Singh B Mutagenesis; 2004 Nov; 19(6):483-8. PubMed ID: 15548761 [TBL] [Abstract][Full Text] [Related]
71. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases]. Eule H; Werner E; Winsel K; Iwainsky H Pharmazie; 1985 Apr; 40(4):276-7. PubMed ID: 4011667 [No Abstract] [Full Text] [Related]
73. [Lepromatous leprosy after BCG vaccination]. Texier L; Maleville J; Geniaux M; Gauthier O; Delaunay MM Med Cutan Ibero Lat Am; 1975; 3(5):381-2. PubMed ID: 1084945 [TBL] [Abstract][Full Text] [Related]
74. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy. Paul S; Rose ET Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625 [No Abstract] [Full Text] [Related]
75. [Efficacy of a daily dosage of dapsone combined with a single dose of rifampicin. Clinical, bacteriological and histopathological evaluation]. Le KD; Nguyen N; Nguyen VM Acta Leprol; 1981; 85():75-82. PubMed ID: 6805238 [No Abstract] [Full Text] [Related]